Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis
Authors:
- Miriam L. FichtnerMFMiriam L. Fichtner
- Casey VieniCVCasey Vieni
- Rachel L. RedlerRRRachel L. Redler
- Ljuvica KolichLKLjuvica Kolich
- Ruoyi JiangRJRuoyi Jiang
- Kazushiro TakataKTKazushiro Takata
- Panos StathopoulosPSPanos Stathopoulos
- Pablo A. SuarezPSPablo A. Suarez
- Richard J. NowakRNRichard J. Nowak
- Steven J. BurdenSBSteven J. Burden
- Damian C. EkiertDEDamian C. Ekiert
- Kevin C. O’cOnnorKOKevin C. O’cOnnor
Open Access
- 20 August 2020
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (12)
Abstract
Pathogenic muscle-specific tyrosine kinase (MuSK)–specific IgG4 autoantibodies in autoimmune myasthenia gravis (MG) are functionally monovalent as a result of Fab-arm exchange. The development of these unique autoantibodies is not well understood. We examined MG patient–derived monoclonal autoantibodies (mAbs), their corresponding germline-encoded unmutated common ancestors (UCAs), and monovalent antigen-binding fragments (Fabs) to investigate how affinity maturation contributes to binding and immunopathology. Mature mAbs, UCA mAbs, and mature monovalent Fabs bound to MuSK and demonstrated pathogenic capacity. However, monovalent UCA Fabs bound to MuSK but did not have measurable pathogenic capacity. Affinity of the UCA Fabs for MuSK was 100-fold lower than the subnanomolar affinity of the mature Fabs. Crystal structures of two Fabs revealed how mutations acquired during affinity maturation may contribute to increased MuSK-binding affinity. These findings indicate that the autoantigen drives autoimmunity in MuSK MG through the accumulation of somatic mutations such that monovalent IgG4 Fab-arm–exchanged autoantibodies reach a high-affinity threshold required for pathogenic capacity.Keywords
All Related Versions
Funding Information
- National Institute of Allergy and Infectious Diseases (R01-AI114780, R21-AI142198)
- National Institutes of Health (U54-NS115054)
- Muscular Dystrophy Association (MDA575198)
- Colton Center for Autoimmunity
- Onassis Foundation (R ZO 006/2018-2019)
This publication has 64 references indexed in Scilit:
- Bulk-solvent and overall scaling revisited: faster calculations, improved resultsActa Crystallographica Section D Structural Biology, 2013
- Linking Crystallographic Model and Data QualityScience, 2012
- B cells and autoimmunityCurrent Opinion in Immunology, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009
- Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursorsProceedings of the National Academy of Sciences, 2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Crystal Structure of the Agrin-responsive Immunoglobulin-like Domains 1 and 2 of the Receptor Tyrosine Kinase MuSKJournal of Molecular Biology, 2006
- Prediction of post‐translational glycosylation and phosphorylation of proteins from the amino acid sequenceProteomics, 2004